This study investigated the effects of Galileo Therapy in Cerebral Palsy (CP, GMFCS 1&2, age 5-9) (Cologne Concept: 3×3 minutes, 10 session/week, 26 weeks) on walking distance (1MWT). Galileo Therapy showed a significant increase after 6 months (+17%) while there was no further increase in the following 6 months without Galileo but with individual standard therapy…
This study investigated short-term effects of Galileo Therapy (16-25Hz, pos. 1,5-3, 1 min., 10° knee angle, fore-foot stance) in children with spastic Cerebral Palsy (CP, GMFCS 2-4, 4-12 Jahre). The results show a massive decrease in cocontraction (26% to 54%) and hence and increase in voluntary muscle activation (#GRFS165). Both effects explain are essential for reduction of Spasticity when using Galileo Therapy…
This study investigated short-term effects of Galileo Therapy (16-25Hz, pos. 1,5-3, 1 min., 10° knee angle, fore-foot stance) in children with spastic Cerebral Palsy (CP, GMFCS 2-4, 4-12 Jahre). The mechanical reflex (-12%), active Range of Motion (+15%) and the voluntary muscle activation (+17, +37%) was measured. The observed significant improvements explain why Galileo Therapy is so effective in Spasticity Management…
This study investigated the effects of Galileo Therapy in Cerebral Palsy (CP, GMFCS 1&2, age 5-10) (Cologne Concept: 3×3 minutes, 10 session/week, 26 weeks) on walking distance (6MWT). Galileo Therapy showed a significant increase in walking distance after 6 months (+17%) while there was no further increase in the following 6 months without Galileo but with individual standard therapy…
This study investigated the effects of Galileo Therapy in Spinal Muscle Atrophy (SMA, type II, III, IIIa, age 2-7) (Cologne Concept: 3×3 minutes, 10 session/week, 26 weeks). Galileo Therapy showed significant improvements in muscle function in Gross Motor Function Test (GMFM-66, +4%) and Hammersmith Functional Mobility Scale (HFMS, +9,5%). The following 6 months of standard therapy did not show further significant improvements…
This study investigated the effects of Galileo Therapy in children with CP (Cerebral Palsy) and other neuro-muscular conditions within the Cologne therapy concept “auf die Beine” on motoric function and bone mass (10-20Hz, patient individual exercises, 10*15min./week, 6 months + 6 months follow-up). The Galileo Therapy showed an improvement of bone mass by +6,5% and of different aspects of motoric function of up to +35%…
This study documented the effects of Galileo Training in children with OI (Osteogenesis Imperfecta) during the Cologne therapy concept “auf die Beine” on muscle function and muscle mass (10-20Hz, patient individual exercises, 10*15min./week, 6 months + 6 months follow-up). The results showed a significant growth corrected increase of muscle mass (+7%), an significant increase of leg force (+7%) and of the GMFM66 (+9%)…
This study documented the effects of Galileo Training in children with OI (Osteogenesis Imperfecta) during the Cologne therapy concept “auf die Beine” on muscle and bone mass (10-20Hz, patient individual exercises, 10*15min./week, 6 months + 6 months follow-up). The results show a growth effect corrected significant increase in muscle mass (legs up to 14%) and bone mass (leg up to 31%)…
This study documented the Effects of 6 month of home based Galileo Therapy (Cologne Concept) on bone parameters and muscle function in Children with Cerebral Palsy (CP, GMFM I-V, 2/day, 3*3 min., 6 months, individualize exercises). Galileo Therapy showed highly significant improvements in muscle mass (+3%), bone mass (+5.9%), muscle force /+7.8%) and muscle function & mobility (+12.8% mGFMF)…
This study evaluated the effects of 6 months of Galileo Therapy in Osteogenesis Imperfecta (OI) patients (Cologne Concept, 10 units/week, 6 months, 15-20Hz, individual exercises). The Galileo Therapy showed significant increase in muscle function (e.g. GMFM66 or walking distance) of up to 43%, an increase of muscle mass in the legs and pelvis of 8% and total body bone mineral content (BMC) of 21%…
© 2008-2025 Novotec Medical GmbH
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information
